|Date Requested:February 07, 2011
Time Requested:01:38 PM
| FUND(S) |
Sources of Revenue
Legislation creates:Neither Program nor Fund
Effect this measure will have on costs and revenues of state government.
| The purpose of this bill is to add language to West Virginia Code §60A-10-7 requiring the issuance of a lawful prescription for dispensing drug products containing as an active ingredient ephedrine, pseudoephedrine, phenylpropanolamine and other chemical precursors of methamphetamine
The Public Employees Insurance Agency (PEIA) acquired information from the WV Board of Pharmacy that shows an estimated monthly number of 30,000 pseudoephedrine sales reported for the period October 2010 through January 2011.
Utilizing a 16% share of the market at the current volume of claims this equates to 57,600 units of the proposed drugs. Assuming four prescriptions per office visit this would be 14,400 office visits that would be incurred. A doctors office visit is averaging approximately $55.00. Annual cost is projected to be approximately $800,000.00 for FY-2012.
A separate scenario assuming the legitimate market is half of the current market and that users would switch to other over the counter products would reduce the number of office visits to 7,200. Annual cost in this scenario is projected to be approximately $400,000.00 for FY-2012.
With the information available a range of $400,000.00 to $800,000.00 for FY-2012 is our best estimate of the cost of passage of this bill. Future fiscal year cost would be trended at 10%.
The additional cost to cover this legislation would either have to come from the General Revenue Fund in the form of an appropriation or by increasing premium to both employees and employers.
|Effect of Proposal||Fiscal Year|
|1. Estmated Total Cost||0||0||0|
|Repairs and Alterations||0||0||0|
|2. Estimated Total Revenues||0||0||0|
3. Explanation of above estimates (including long-range effect):